2nd Circ. Won't Push $881M Cannabis IP Fight Into Arbitration
The Second Circuit on Thursday affirmed a lower court's decision rebuffing biotechnology company Amyris' arbitration bid in cannabinoid maker Lavvan's $881 million patent and trade secrets suit over cannabis development, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article